Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nairn

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|January 14, 2010
Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelinesD G Grosset, G J A Macphee, M Nairn, et al.
British Medical Journal|September 13, 1980
Changes in glycosylated haemoglobin after poor control in insulin-dependent diabeticsA P Brooks, I M Nairn, J D Baird
Diabetes Care|November 1, 1983
Urinary cortisol-creatinine ratio and nocturnal hypoglycemiaA E Ohwovoriole, I M Nairn, J D Baird
Audiology Research|June 2, 2021
Review of Bone Conduction Hearing DevicesSusan E Ellsperman, Emily M Nairn, Emily Z Stucken
Postgraduate Medical Journal|December 1, 1982
Impaired ACTH and glucagon response to hypoglycaemia in an insulin-treated diabeticA E Ohwovoriole, I M Nairn, J Bevan, et al.
Biochemical Society Transactions|February 27, 1999
Comparison of polyamine analogue toxicity in two cell lines (HL-60 & MCF-7)L M Nairn, P M Woster, G S Lindsay, et al.
Journal of Cellular Physiology|January 7, 2000
Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cellsL M Nairn, G S Lindsay, P M Woster, et al.
Diabete & Metabolisme|March 1, 1981
Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamideB M Frier, J P Ashby, I M Nairn, et al.
Anaesthesia and Intensive Care|May 1, 1991
Tests of six continuous flow CPAP devicesY Shehabi, K M Hillman, M Nairn, et al.
Journal of the Royal Society of Medicine|August 1, 1979
Bromocriptine and acromegaly: therapeutic implicationsA P Brooks, P J Stephen, I M Nairn, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|January 14, 2010
Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelinesD G Grosset, G J A Macphee, M Nairn, et al.
British Medical Journal|September 13, 1980
Changes in glycosylated haemoglobin after poor control in insulin-dependent diabeticsA P Brooks, I M Nairn, J D Baird
Diabetes Care|November 1, 1983
Urinary cortisol-creatinine ratio and nocturnal hypoglycemiaA E Ohwovoriole, I M Nairn, J D Baird
Audiology Research|June 2, 2021
Review of Bone Conduction Hearing DevicesSusan E Ellsperman, Emily M Nairn, Emily Z Stucken
Postgraduate Medical Journal|December 1, 1982
Impaired ACTH and glucagon response to hypoglycaemia in an insulin-treated diabeticA E Ohwovoriole, I M Nairn, J Bevan, et al.
Biochemical Society Transactions|February 27, 1999
Comparison of polyamine analogue toxicity in two cell lines (HL-60 & MCF-7)L M Nairn, P M Woster, G S Lindsay, et al.
Journal of Cellular Physiology|January 7, 2000
Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cellsL M Nairn, G S Lindsay, P M Woster, et al.
Diabete & Metabolisme|March 1, 1981
Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamideB M Frier, J P Ashby, I M Nairn, et al.
Anaesthesia and Intensive Care|May 1, 1991
Tests of six continuous flow CPAP devicesY Shehabi, K M Hillman, M Nairn, et al.
Journal of the Royal Society of Medicine|August 1, 1979
Bromocriptine and acromegaly: therapeutic implicationsA P Brooks, P J Stephen, I M Nairn, et al.
Pageof 5